Determining eliciting doses in walnut allergic patients

Determining eliciting doses in walnut allergic patients - Determining eliciting doses in walnut allergic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON41503

Enrollment

Registered

2012-01-25

Start date

2012-11-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

food allergy walnut allergy

Interventions

Food challenge with walnut food for all participants

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age 18 years or older - suspected history of adverse type I allergic reaction to walnut

Exclusion criteria

Exclusion criteria: - congenital/acquired immune disorder - lymfoproliferative disease - use of systemic immune suppressants - pregnancy - use of beta blockers - severe asthma, defined as FEV1

Design outcomes

Primary

Measure	Time frame
Establishing an eliciting dose distribution for walnut on population level by determining individual eliciting doses in double-blind placebo controlled food challenges.	—

Secondary

Measure	Time frame
Identifying biomarkers that play a role in a food allergic reaction.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)